AzTrials
AzTrials

Treatment of PeriodontitisNCT06835452

Comparison of Current Subgingival Debridement Methods

An observational study of Treatment of Periodontitis and Guided Biofilm Therapy, run by Hacettepe University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Our study aimed to compare the effectiveness of current subgingival debridement methods used in the treatment of Stage 1 and Stage 2 periodontitis patients, the aesthetic condition achieved after these treatments, and the pain felt during treatment. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Type of treatment
Pill or oral medicine
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
24 Jul 2024to 7 Feb 2025
How long will I take part?
6 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: 90 female patients with stage 1-2 periodontitis

Who may be able to join

  • Systemically healthy patient (without known chronic disease)
  • Periodontal diagnostic data (Gingival Index, Plaque Index, Periodontal pocket depths, Attachment loss, Radiological data-Bone loss data) are complete
  • Treatments diagnosed with stage 1-2 periodontitis and those who have not had periodontal treatment in the last 6 months

Who cannot join

  • Having a systemic disease
  • Pregnant and lactating women
  • smoker
  • Those who do not want to participate in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Nigde Omer Halisdemir University

    Niğde

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Current Subgingival Debridement Methods: Clinical Trial with 6 Months Follow-up

Our study aimed to compare the effectiveness of current subgingival debridement methods used in the treatment of Stage 1 and Stage 2 periodontitis patients, the aesthetic condition achieved after these treatments, and the pain felt during treatment.

90 female patients who were diagnosed with chronic periodontitis (Stage 1-2) and required supra-subgingival scaling for treatment purposes, and who volunteered to participate in the study, were included in the study. Three treatment groups were determined. 30 people were included in each group. Periodontal examination was performed before and after the treatments in the 1st month, 3rd month and 6th month and the data on the collected periodontal parameters were analyzed.

Read the detailed description

Periodontal parametreler Gingival index, plaque index, periodontal pocket depth and bleeding index on probing.

It was evaluated with the visual analog scale for pain and aesthetics.

Keywords
guided biofilm therapy, periodontitis, subgingival debridement
Medical subject headings
Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06835452
Study groupRoleWhat they receive
Group 1- classic treatmentSubgingival debridement was performed using the Cavitron and Gracey curette (this is the method that is used routinely).
Group 2-Guided Biofilm TherapySubgingival debridement was performed with the Guided Biofilm Therapy (GBT+Airabrasion) method. This method is the most up-to-date method. The biofilm is shown to the patient with plate dye, and the biofilm is cleaned with air abrasion and perio flow (EMS device cavitron). In the patient's control sessions, the patient's oral hygiene motivation is tried to be increased by dyeing the biofilm.
Group 3- Classical treatment and with Plaque paintthe dental calculus and biofilm were stained with plaque paint, shown to the patient with the help of a mirror, and then routine subgingival debridement was performed.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gingival index

    4 surfaces of all teeth (distal, buccal, mesial, lingual) are evaluated 0= Normal gingiva

    1. Mild inflammation - slight discoloration, slight edema. There is no bleeding after probing.
    2. Moderate inflammation - redness, edema and shine. Bleeding after probing.
    3. Severe inflammation - marked redness and edema. Ulceration. Tendency to spontaneous bleeding.

    Measured: baseline, 1st month, 3rd month and 6th month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2025
  2. Study start24 Jul 2024
  3. Primary completion1 Feb 2025
  4. Study completion7 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
90 participants (actual)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT06835452
Sponsor's protocol ID
2023/65
Status last verified
Feb 2025
First submitted
14 Feb 2025
Last updated
19 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Treatment of Periodontitis and Guided Biofilm Therapy, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gingival index (time frame: baseline, 1st month, 3rd month and 6th month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in